Cargando…
Risk Factors in Neuroleptic Malignant Syndrome
Neuroleptic malignant syndrome (NMS) is an uncommon but potentially serious idiosyncratic response to neuroleptic antipsychotics. It usually affects young males, but the risk has been seen to increase with certain factors including the administration practices of antipsychotic neuroleptics in these...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951537/ https://www.ncbi.nlm.nih.gov/pubmed/21206810 |
_version_ | 1782187710119673856 |
---|---|
author | Gupta, Vinay Magon, Rakesh Mishra, B.P. Sidhu, G.B.S. Mahajan, Ranjiv |
author_facet | Gupta, Vinay Magon, Rakesh Mishra, B.P. Sidhu, G.B.S. Mahajan, Ranjiv |
author_sort | Gupta, Vinay |
collection | PubMed |
description | Neuroleptic malignant syndrome (NMS) is an uncommon but potentially serious idiosyncratic response to neuroleptic antipsychotics. It usually affects young males, but the risk has been seen to increase with certain factors including the administration practices of antipsychotic neuroleptics in these individuals. Even though no predictors for NMS are yet known, this article highlights the findings on certain risk factors as seen from a series of fifteen patients who developed NMS. Cautious use of neuroleptics in those at risk, early recognition and institution of immediate management is important. |
format | Text |
id | pubmed-2951537 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2003 |
publisher | Medknow Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-29515372011-01-04 Risk Factors in Neuroleptic Malignant Syndrome Gupta, Vinay Magon, Rakesh Mishra, B.P. Sidhu, G.B.S. Mahajan, Ranjiv Indian J Psychiatry Original Article Neuroleptic malignant syndrome (NMS) is an uncommon but potentially serious idiosyncratic response to neuroleptic antipsychotics. It usually affects young males, but the risk has been seen to increase with certain factors including the administration practices of antipsychotic neuroleptics in these individuals. Even though no predictors for NMS are yet known, this article highlights the findings on certain risk factors as seen from a series of fifteen patients who developed NMS. Cautious use of neuroleptics in those at risk, early recognition and institution of immediate management is important. Medknow Publications 2003 /pmc/articles/PMC2951537/ /pubmed/21206810 Text en Copyright: © Indian Journal of Psychiatry http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Gupta, Vinay Magon, Rakesh Mishra, B.P. Sidhu, G.B.S. Mahajan, Ranjiv Risk Factors in Neuroleptic Malignant Syndrome |
title | Risk Factors in Neuroleptic Malignant Syndrome |
title_full | Risk Factors in Neuroleptic Malignant Syndrome |
title_fullStr | Risk Factors in Neuroleptic Malignant Syndrome |
title_full_unstemmed | Risk Factors in Neuroleptic Malignant Syndrome |
title_short | Risk Factors in Neuroleptic Malignant Syndrome |
title_sort | risk factors in neuroleptic malignant syndrome |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951537/ https://www.ncbi.nlm.nih.gov/pubmed/21206810 |
work_keys_str_mv | AT guptavinay riskfactorsinneurolepticmalignantsyndrome AT magonrakesh riskfactorsinneurolepticmalignantsyndrome AT mishrabp riskfactorsinneurolepticmalignantsyndrome AT sidhugbs riskfactorsinneurolepticmalignantsyndrome AT mahajanranjiv riskfactorsinneurolepticmalignantsyndrome |